99 related articles for article (PubMed ID: 25471020)
1. EGFR inhibitor Gefitinib attenuates posterior capsule opacification in vitro and in the ex vivo human capsular bag model.
Wertheimer C; Siedlecki J; Kook D; Mayer WJ; Wolf A; Klingenstein A; Kampik A; Eibl-Lindner K
Graefes Arch Clin Exp Ophthalmol; 2015 Mar; 253(3):409-17. PubMed ID: 25471020
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic potential of a dual mTORC1/2 inhibitor for the prevention of posterior capsule opacification: An in vitro study.
Feng H; Yang Z; Bai X; Yang M; Fang Y; Zhang X; Guo Q; Ning H
Int J Mol Med; 2018 Apr; 41(4):2099-2107. PubMed ID: 29344639
[TBL] [Abstract][Full Text] [Related]
3. Dual function of TGFβ in lens epithelial cell fate: implications for secondary cataract.
Boswell BA; Korol A; West-Mays JA; Musil LS
Mol Biol Cell; 2017 Apr; 28(7):907-921. PubMed ID: 28209733
[TBL] [Abstract][Full Text] [Related]
4. Fabrication of a 3D bioprinting model for posterior capsule opacification using GelMA and PLMA hydrogel-coated resin.
Liu X; Li J; Liu S; Long Y; Kang C; Zhao C; Wei L; Huang S; Luo Y; Dai B; Zhu X
Regen Biomater; 2024; 11():rbae020. PubMed ID: 38529352
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical Findings of Lens Capsules Obtained from Dead Bag Syndrome Patients.
Sumioka T; Werner L; Yasuda S; Okada Y; Mamalis N; Ishikawa N; Saika S
J Cataract Refract Surg; 2024 May; ():. PubMed ID: 38711217
[TBL] [Abstract][Full Text] [Related]
6. Tonic ErbB signaling underlies TGFβ-induced activation of ERK and is required for lens cell epithelial to myofibroblast transition.
VanSlyke JK; Boswell BA; Musil LS
Mol Biol Cell; 2024 Mar; 35(3):ar35. PubMed ID: 38170570
[TBL] [Abstract][Full Text] [Related]
7. Identification of Small Molecules for Prevention of Lens Epithelium-Derived Cataract Using Zebrafish.
Taler K; Zatari N; Lone MI; Rotem-Bamberger S; Inbal A
Cells; 2023 Oct; 12(21):. PubMed ID: 37947618
[TBL] [Abstract][Full Text] [Related]
8. ErbBs in Lens Cell Fibrosis and Secondary Cataract.
VanSlyke JK; Boswell BA; Musil LS
Invest Ophthalmol Vis Sci; 2023 Jul; 64(10):6. PubMed ID: 37418274
[TBL] [Abstract][Full Text] [Related]
9. Advances in interdisciplinary medical and engineering research of intraocular lens surface modifications to prevent posterior capsule opacification.
Zhang Y; Jiang J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Dec; 47(12):1754-1762. PubMed ID: 36748388
[TBL] [Abstract][Full Text] [Related]
10. Risk assessment and molecular mechanism study of drug-drug interactions between rivaroxaban and tyrosine kinase inhibitors mediated by CYP2J2/3A4 and BCRP/P-gp.
Zhao T; Li X; Chen Y; Du J; Chen X; Wang D; Wang L; Zhao S; Wang C; Meng Q; Sun H; Liu K; Wu J
Front Pharmacol; 2022; 13():914842. PubMed ID: 36071847
[TBL] [Abstract][Full Text] [Related]
11. Posterior Capsule Opacification: A Review of Experimental Studies.
Konopińska J; Młynarczyk M; Dmuchowska DA; Obuchowska I
J Clin Med; 2021 Jun; 10(13):. PubMed ID: 34199147
[TBL] [Abstract][Full Text] [Related]
12. Role of Decorin in Posterior Capsule Opacification and Eye Lens Development.
Shibata S; Shibata N; Ohtsuka S; Yoshitomi Y; Kiyokawa E; Yonekura H; Singh DP; Sasaki H; Kubo E
Cells; 2021 Apr; 10(4):. PubMed ID: 33918979
[TBL] [Abstract][Full Text] [Related]
13. A Critical Appraisal of New Developments in Intraocular Lens Modifications and Drug Delivery Systems for the Prevention of Cataract Surgery Complications.
Mylona I; Tsinopoulos I
Pharmaceuticals (Basel); 2020 Dec; 13(12):. PubMed ID: 33302370
[TBL] [Abstract][Full Text] [Related]
14. Research Progress of Drug Prophylaxis for Lens Capsule Opacification after Cataract Surgery.
Zhang RP; Xie ZG
J Ophthalmol; 2020; 2020():2181685. PubMed ID: 32714607
[TBL] [Abstract][Full Text] [Related]
15. The human capsular bag model of posterior capsule opacification.
Wormstone IM
Eye (Lond); 2020 Feb; 34(2):225-231. PubMed ID: 31745327
[TBL] [Abstract][Full Text] [Related]
16. Cataract surgeon viewpoints on the need for novel preventative anti-inflammatory and anti-posterior capsular opacification therapies.
Shihan MH; Novo SG; Duncan MK
Curr Med Res Opin; 2019 Nov; 35(11):1971-1981. PubMed ID: 31328581
[No Abstract] [Full Text] [Related]
17. Premacular membranes in tissue culture.
Vogt D; Vielmuth F; Wertheimer C; Hagenau F; Guenther SR; Wolf A; Spindler V; Priglinger SG; Schumann RG
Graefes Arch Clin Exp Ophthalmol; 2018 Sep; 256(9):1589-1597. PubMed ID: 29931427
[TBL] [Abstract][Full Text] [Related]
18. Advances in studies of tyrosine kinase inhibitors and their acquired resistance.
Jiao Q; Bi L; Ren Y; Song S; Wang Q; Wang YS
Mol Cancer; 2018 Feb; 17(1):36. PubMed ID: 29455664
[TBL] [Abstract][Full Text] [Related]
19. A cell culture technique for human epiretinal membranes to describe cell behavior and membrane contraction in vitro.
Wertheimer C; Eibl-Lindner KH; Compera D; Kueres A; Wolf A; Docheva D; Priglinger SG; Priglinger C; Schumann RG
Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2147-2155. PubMed ID: 28782074
[TBL] [Abstract][Full Text] [Related]
20. Sprouty2 Suppresses Epithelial-Mesenchymal Transition of Human Lens Epithelial Cells through Blockade of Smad2 and ERK1/2 Pathways.
Tan X; Zhu Y; Chen C; Chen X; Qin Y; Qu B; Luo L; Lin H; Wu M; Chen W; Liu Y
PLoS One; 2016; 11(7):e0159275. PubMed ID: 27415760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
